CD8A and neoplasm: Immune cell profiling of spleen and tumor tissue revealed that B. breve strains alone augmented anti-tumor immunity by increasing CD8+ T and effector CD8+ T cell numbers, and by increasing the CD8+/Treg and effector CD8+/Treg ratio.